ONE PARTNER Trademark

Trademark Overview

On Monday, December 29, 2003, a trademark application was filed for ONE PARTNER with the United States Patent and Trademark Office. The USPTO has given the ONE PARTNER trademark a serial number of 78346065. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Wednesday, March 2, 2005. This trademark is owned by Quintiles Transnational Corp.. The ONE PARTNER trademark is filed in the Advertising, Business and Retail Services and Insurance & Financial Services categories with the following description:

business services in the pharmaceutical, biotechnology and life sciences fields, namely, advising and assisting clients in the development and commercialization of products and management of product portfolios

providing financial services in the pharmaceutical, biotechnology and life sciences fields; namely, providing financing to pharmaceutical, biotechnology and life sciences companies for product development and commercialization, making acquisitions of products and product rights of and investments in pharmaceutical, biotechnology and life sciences companies and indirect investments in life science venture funds to aid pharmaceutical, biotechnology and life sciences companies in the development and commercialization of new products, management of product portfolios, prioritization of financial resources and achievement of financial objectives and providing financial consultation in connection therewith
one partner

General Information

Serial Number78346065
Word MarkONE PARTNER
Filing DateMonday, December 29, 2003
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateWednesday, March 2, 2005
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and Servicesbusiness services in the pharmaceutical, biotechnology and life sciences fields, namely, advising and assisting clients in the development and commercialization of products and management of product portfolios
Goods and Servicesproviding financial services in the pharmaceutical, biotechnology and life sciences fields; namely, providing financing to pharmaceutical, biotechnology and life sciences companies for product development and commercialization, making acquisitions of products and product rights of and investments in pharmaceutical, biotechnology and life sciences companies and indirect investments in life science venture funds to aid pharmaceutical, biotechnology and life sciences companies in the development and commercialization of new products, management of product portfolios, prioritization of financial resources and achievement of financial objectives and providing financial consultation in connection therewith

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateThursday, January 8, 2004
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class036 - Insurance; financial affairs; monetary affairs; real estate affairs.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateThursday, January 8, 2004
Primary Code036
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameQuintiles Transnational Corp.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDurham, NC 27703

Trademark Events

Event DateEvent Description
Wednesday, March 2, 2005ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Wednesday, March 2, 2005ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Thursday, July 29, 2004NON-FINAL ACTION E-MAILED
Monday, July 26, 2004ASSIGNED TO EXAMINER
Tuesday, June 15, 2004PAPER RECEIVED
Thursday, January 8, 2004NEW APPLICATION ENTERED IN TRAM

Related Keywords

partner life biotechnology sciences pharmaceutical product financial commercialization products development companies